About me
Pharmaceutical Sciences, CMC, and Innovation Leader with 23 years of end-to-end drug product development across biologics and small molecules from preclinical research through commercial launch. Currently leading device-enabled subcutaneous delivery programs for high-dose biologics across Immunology, Oncology, and Neuroscience, including lifecycle management strategy. Deep expertise in high-concentration/large-volume SC delivery, device integration, technology transfer, scale-up, and PPQ/manufacturing readiness. Proven track record leading global, cross-functional teams across BMS/Celgene and Novartis to deliver fit-for-purpose CMC strategies and commercial launch.
